EU OKs $5B Deal Joining IMS Health, Investment Funds

By Jacqueline Bell

Law360, New York (February 03, 2010, 12:29 PM ET) -- European competition authorities have signed off on TPG Capital LP and Canada-based pension manager CPP Investment Board's $5.2 billion deal to acquire IMS Health Inc., finding that the transaction would not significantly curb competition in Europe.

The European Commission said Wednesday there are no horizontal overlaps between the activities of IMS and companies owned by the investment funds, but noted that the deal would lead to a vertical relationship between the supply of pharmaceutical market research services provided by IMS and the development and marketing of...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles